MXPA05000978A - Formulaciones farmaceuticas novedosas de comienzo rapido que contienen un compuesto para la disfucion sexual que comprenden polvo de cacao y uso de las mismas. - Google Patents
Formulaciones farmaceuticas novedosas de comienzo rapido que contienen un compuesto para la disfucion sexual que comprenden polvo de cacao y uso de las mismas.Info
- Publication number
- MXPA05000978A MXPA05000978A MXPA05000978A MXPA05000978A MXPA05000978A MX PA05000978 A MXPA05000978 A MX PA05000978A MX PA05000978 A MXPA05000978 A MX PA05000978A MX PA05000978 A MXPA05000978 A MX PA05000978A MX PA05000978 A MXPA05000978 A MX PA05000978A
- Authority
- MX
- Mexico
- Prior art keywords
- dysfunction
- compound
- cocoa powder
- pharmaceutical formulations
- containing rapid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Confectionery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una formulacion farmaceutica de comienzo rapido que contiene un compuesto para la disfuncion sexual que comprende polvo de cacao, proceso para la manufactura de la composicion y uso de la composicion en terapia para la disfuncion sexual.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202365A SE0202365D0 (sv) | 2002-08-05 | 2002-08-05 | New formulation and use thereof |
PCT/SE2003/001022 WO2004012702A1 (en) | 2002-08-05 | 2003-06-18 | New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05000978A true MXPA05000978A (es) | 2005-12-12 |
Family
ID=20288677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05000978A MXPA05000978A (es) | 2002-08-05 | 2003-06-18 | Formulaciones farmaceuticas novedosas de comienzo rapido que contienen un compuesto para la disfucion sexual que comprenden polvo de cacao y uso de las mismas. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1539096A1 (es) |
JP (1) | JP2005539008A (es) |
CN (1) | CN1674866B (es) |
AR (1) | AR040797A1 (es) |
AU (1) | AU2003239038B2 (es) |
BR (1) | BR0313224A (es) |
CA (1) | CA2495527C (es) |
IL (1) | IL166031A0 (es) |
MX (1) | MXPA05000978A (es) |
NZ (1) | NZ537520A (es) |
RU (1) | RU2312665C2 (es) |
SE (1) | SE0202365D0 (es) |
TW (1) | TW200418470A (es) |
WO (1) | WO2004012702A1 (es) |
ZA (1) | ZA200500051B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
DE102005009240A1 (de) | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
GB0509317D0 (en) * | 2005-05-06 | 2005-06-15 | Clarke Anthony | Pharmaceutical formulation of apomorphine |
DE102010024866A1 (de) * | 2010-06-24 | 2011-12-29 | Pharmatech Gmbh | Formulierung zur Geschmacksmaskierung |
ES2934136T3 (es) | 2016-09-21 | 2023-02-17 | Lts Lohmann Therapie Systeme Ag | Forma de dosificación oral |
EP3758675A1 (de) | 2018-03-01 | 2021-01-06 | LTS Lohmann Therapie-Systeme AG | Orale darreichungsform mit theobrominfreiem kakao |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4755180A (en) * | 1986-06-16 | 1988-07-05 | Alza Corporation | Dosage form comprising solubility regulating member |
FR2717387B1 (fr) * | 1994-03-17 | 1996-10-18 | Hi Pharmtech | Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline. |
US6121276A (en) | 1994-04-22 | 2000-09-19 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
ES2105970B1 (es) * | 1995-08-02 | 1998-07-01 | S A L V A T Lab Sa | Composicion farmaceutica oral de ciprofloxacino, no acuosa, estable y con caracteristicas organolepticas mejoradas. |
CA2178021C (en) * | 1996-04-19 | 1999-09-28 | Theodore H. Stanley | Tobacco substitute |
KR20000069899A (ko) * | 1997-01-06 | 2000-11-25 | 디. 제이. 우드, 스피겔 알렌 제이 | 속방성 및 미각 차폐성 약제학적 용량 형태 |
GT199900061A (es) * | 1998-05-15 | 2000-10-14 | Pfizer | Formulaciones farmaceuticas. |
JP2000095710A (ja) * | 1998-09-21 | 2000-04-04 | Taisho Pharmaceut Co Ltd | カカオ末を配合した経口用固形製剤 |
JP2000119198A (ja) * | 1998-10-16 | 2000-04-25 | Eisai Co Ltd | 苦味等の隠蔽されたホスフォジエステラーゼ阻害剤含有経口製剤 |
US6060094A (en) * | 1998-10-30 | 2000-05-09 | Nestec S.A. | Method of reducing fat in fat-based coating for confectionery products |
SE9803986D0 (sv) * | 1998-11-23 | 1998-11-23 | Pharmacia & Upjohn Ab | New compositions |
US6531114B1 (en) * | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
SI20109A (sl) * | 1998-12-16 | 2000-06-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Stabilna farmacevtska formulacija |
US6291471B1 (en) | 1998-12-17 | 2001-09-18 | Abb Holdings, Inc. | Use of apomorphine for the treatment of organic erectile dysfunction in males |
US6455564B1 (en) * | 1999-01-06 | 2002-09-24 | Pharmacia & Upjohn Company | Method of treating sexual disturbances |
US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
AU779991B2 (en) | 1999-08-10 | 2005-02-24 | Board Of Regents, The University Of Texas System | Method for increasing optic nerve, choroidal and retinal blood flow to facilitate the preservation of sight |
JP2001114668A (ja) * | 1999-10-13 | 2001-04-24 | Meiji Seika Kaisha Ltd | チョコレート剤 |
PL366204A1 (en) | 1999-12-30 | 2005-01-24 | Tap Holdings, Inc. | Oral mucosal dosage forms of apomorphine |
AU2001273545A1 (en) | 2000-07-19 | 2002-01-30 | Lavipharm Laboratories, Inc. | Sildenafil citrate solid dispersions having high water solubility |
JP2002193839A (ja) * | 2000-12-27 | 2002-07-10 | Meiji Seika Kaisha Ltd | ココア製剤 |
CA2435546A1 (en) * | 2001-02-08 | 2002-08-15 | Alice C. Martino | Rapid-onset medicament for the treatment of sexual dysfunction |
US20020172732A1 (en) * | 2001-03-21 | 2002-11-21 | Wies Ter Laak | Composition comprising cocoa |
-
2002
- 2002-08-05 SE SE0202365A patent/SE0202365D0/xx unknown
-
2003
- 2003-06-18 CA CA002495527A patent/CA2495527C/en not_active Expired - Fee Related
- 2003-06-18 EP EP03733755A patent/EP1539096A1/en not_active Ceased
- 2003-06-18 RU RU2005102835/15A patent/RU2312665C2/ru not_active IP Right Cessation
- 2003-06-18 NZ NZ537520A patent/NZ537520A/en not_active IP Right Cessation
- 2003-06-18 JP JP2004525901A patent/JP2005539008A/ja active Pending
- 2003-06-18 CN CN038188910A patent/CN1674866B/zh not_active Expired - Fee Related
- 2003-06-18 AU AU2003239038A patent/AU2003239038B2/en not_active Ceased
- 2003-06-18 MX MXPA05000978A patent/MXPA05000978A/es active IP Right Grant
- 2003-06-18 BR BR0313224-2A patent/BR0313224A/pt not_active Application Discontinuation
- 2003-06-18 WO PCT/SE2003/001022 patent/WO2004012702A1/en active Application Filing
- 2003-07-25 TW TW092120418A patent/TW200418470A/zh unknown
- 2003-08-05 AR AR20030102814A patent/AR040797A1/es not_active Application Discontinuation
-
2004
- 2004-12-28 IL IL16603104A patent/IL166031A0/xx unknown
-
2005
- 2005-01-04 ZA ZA2005/00051A patent/ZA200500051B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2003239038B2 (en) | 2008-01-03 |
CA2495527A1 (en) | 2004-02-12 |
RU2005102835A (ru) | 2005-08-10 |
WO2004012702A1 (en) | 2004-02-12 |
TW200418470A (en) | 2004-10-01 |
IL166031A0 (en) | 2006-01-15 |
JP2005539008A (ja) | 2005-12-22 |
ZA200500051B (en) | 2006-12-27 |
SE0202365D0 (sv) | 2002-08-05 |
AR040797A1 (es) | 2005-04-20 |
RU2312665C2 (ru) | 2007-12-20 |
CN1674866B (zh) | 2012-09-26 |
EP1539096A1 (en) | 2005-06-15 |
CN1674866A (zh) | 2005-09-28 |
AU2003239038A1 (en) | 2004-02-23 |
CA2495527C (en) | 2008-12-30 |
BR0313224A (pt) | 2005-07-05 |
NZ537520A (en) | 2006-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0103211D0 (sv) | New formulations and use thereof | |
TW200510375A (en) | New compounds | |
SI1478339T1 (sl) | Farmacevtske formulacije antineoplastičnih sredstev, zlasti temozolomida, postopki za pripravo in uporabo le-teh | |
AU2003297260A1 (en) | Fast-disintegrating solid dosage forms being not friable and comprising pullulan | |
IL157320A0 (en) | Rapid-onset medicament for the treatment of sexual dysfunction | |
HUP0402063A3 (en) | Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof | |
MXPA04008068A (es) | Metodo para administrar moleculas de glp-1. | |
HUP0202719A3 (en) | Pharmaceutical compositions for the treatment of female sexual dysfunctions | |
MXPA04003666A (es) | Uso de flibanserina para tratamiento de trastornos sexuales. | |
IL219397A0 (en) | Compounds for the treatment of metabolic disorders, methods of preparing same, and pharmaceutical compositions containing same | |
HK1167332A1 (en) | Pharmaceutical composition, use thereof and method for making the same | |
DK0703786T3 (da) | Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS | |
PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
IL204947A0 (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use in the manufacture of medicaments, pharmaceutical compositions and kits comprising them | |
TW200503782A (en) | New formulations and use thereof | |
TNSN05046A1 (en) | Method of preparing dry powder inhalation compositions | |
MXPA03010761A (es) | Combinaciones farmaceuticas. | |
SG116507A1 (en) | Pharmaceutical dosage form and method of making. | |
MXPA03008420A (es) | Forma farmaceutica solida oralmente dispersa. | |
WO2003059329A3 (en) | Polytartrate composition | |
SI1404304T1 (sl) | Tableta, obsegajoča cetirizin in psevdoefedrin | |
GR20020100478A (el) | Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης | |
MXPA05000978A (es) | Formulaciones farmaceuticas novedosas de comienzo rapido que contienen un compuesto para la disfucion sexual que comprenden polvo de cacao y uso de las mismas. | |
BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine | |
MY127675A (en) | Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights | ||
FG | Grant or registration |